FDA 510(k)

EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100)

N.º K: K242821 · 2025-02-20

Fecha de decisión2025-02-20

Código de productoQAS

Comité asesorRA

DecisiónSubstantially Equivalent

Resumen del dispositivo

EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100) is the device name listed in this FDA 510(k) record. The listed applicant is Ever Fortune.Ai, Co., Ltd.. It received FDA 510(k) clearance on 2025-02-20 under 510(k) number K242821. The device is classified under product code QAS. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Preguntas frecuentes

What is the EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100)?

EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100) is a medical device that received FDA 510(k) clearance on 2025-02-20. The listed applicant is Ever Fortune.Ai, Co., Ltd.. The 510(k) number is K242821.

When did EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100) receive FDA 510(k) clearance?

EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100) received FDA 510(k) clearance on 2025-02-20, under 510(k) number K242821.

Who is the listed applicant for EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100)?

The FDA 510(k) record lists Ever Fortune.Ai, Co., Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100)?

The FDA product code for EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100) is QAS.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Otros registros que enlistan a Ever Fortune.Ai, Co., Ltd. como solicitante

K253163EFAI ERSUITE CT APPENDICITIS ASSESSMENT SYSTEM (APPEN-CT-100)K251306Seg Pro V3 (RT-300)K241923EFAI Neurosuite CT Midline Shift Assessment System (MLS-CT-100)K234042EFAI Bonesuite XR Bone Age Pro Assessment System (BAP-XR-100)K240291EFAI CARDIOSUITE CTA ACUTE AORTIC SYNDROME ASSESSMENT SYSTEM K231025EFAI NeuroSuite CT ICH Assessment System

Ver todos los 15 dispositivos →

Dispositivos relacionados (Código: QAS)

K260906a2z-Abdo-TriageA2z Radiology Ai, Inc.K261085Rapid Vessel Occlusion (Rapid VO)iSchemaview K260729Vascular Assist Occlusion Triage (VAOT) (v1.0)GuideAI Health K261317BriefCase-TriageAidoc Medical , Ltd.K253163EFAI ERSUITE CT APPENDICITIS ASSESSMENT SYSTEM (APPEN-CT-100)Ever Fortune.Ai, Co., Ltd.K252421JLK-NCCTJLK, Inc.

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.